Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptimmune Therapeutics PLC

0.2382
-0.0018-0.75%
Post-market: 0.2381-0.0001-0.04%18:11 EDT
Volume:302.09K
Turnover:72.64K
Market Cap:61.27M
PE:-0.79
High:0.2461
Open:0.2461
Low:0.2354
Close:0.2400
Loading ...
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 27, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 27, 2019

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
May 15, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
May 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 06, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
May 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
May 06, 2019

Major Issues Report

Current report, items 8.01 and 9.01
May 02, 2019

Major Issues Report

Current report, item 5.07
May 02, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Feb 27, 2019

Major Issues Report

[Amend] Current report, items 2.02 and 9.01
Dec 03, 2018

Correspondence

[Cover]Correspondence
Oct 18, 2018

Correspondence

[Cover]Correspondence
Oct 10, 2018

Beneficial Ownership Change

Oct 03, 2018

Correspondence

[Cover]Correspondence
Mar 29, 2018

Beneficial Ownership Change